Study on Safety and Effectiveness of Ergoferon in the Treatment of Flu / ARVI in Outpatients.

Safety and Efficacy Study of Interferon to Treat Patients Hospitalized for Influenza

NCT01227798 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Efficacy and Safety of Ergoferon for COVID-19 Prevention During Vaccination Against SARS-CoV-2

NCT05069649 ·Status: COMPLETED ·Phase: PHASE3

A Study of Avonex to Determine the Effects of Dose Titration on the Incidence of Flu Like Symptoms in Healthy Volunteers

NCT01119677 ·Status: COMPLETED ·Phase: PHASE1

Clinical Trial of Efficacy and Safety of ММН-407 in the Treatment of Influenza in Outpatient Adults

NCT04250311 ·Status: SUSPENDED ·Phase: PHASE3

Clinical Trial of Efficacy and Safety of Anaferon in the Treatment of Acute Respiratory Viral Infections

NCT03707912 ·Status: COMPLETED ·Phase: PHASE4

Cycloferon for Post-exposure Prophylaxis of Acute Respiratory Viral Infections and Influenza

NCT06183229 ·Status: COMPLETED ·Phase: PHASE3

Study of Efficacy and Safety of DV890 in Patients With COVID-19 Pneumonia

NCT04382053 ·Status: COMPLETED ·Phase: PHASE2

Efficacy of Anaferon for Children in the Treatment of Influenza and Acute Respiratory Viral Infections in Children

NCT02072174 ·Status: COMPLETED ·Phase: PHASE4

Dose-Finding Study of Favipiravir in the Treatment of Uncomplicated Influenza

NCT01068912 ·Status: COMPLETED ·Phase: PHASE2

A Study on Higher-dose Oseltamivir Treatment's Impact on Viral Clearance and Clinical Recovery in Adults Hospitalized With Influenza

NCT01052961 ·Status: COMPLETED ·Phase: PHASE4

Study Evaluating the Efficacy and Safety of AV5080 in Patients With Uncomplicated Influenza

NCT05093998 ·Status: UNKNOWN ·Phase: PHASE3

A Study of S-337395 in Symptomatic Nonhospitalized Adults With Respiratory Syncytial Virus (RSV) Who Are at High Risk of Progression to Severe Disease

NCT07214571 ·Status: RECRUITING ·Phase: PHASE2

Antiviral Therapy for Influenza A H1N1

NCT00985582 ·Status: COMPLETED

Evaluating the Use of Oseltamivir for the Treatment of Influenza in Adults

NCT01314911 ·Status: COMPLETED ·Phase: NA

A Study to Learn About The Study Medicine (Called PF-06823859) in Healthy Chinese Participants

NCT05257798 ·Status: COMPLETED ·Phase: PHASE1

Clinical Trial of Efficacy and Safety of ММН-407 in Acute Respiratory Viral Infection

NCT04244084 ·Status: COMPLETED ·Phase: PHASE3

To Evaluate the Clinical Efficacy and Safety of Recombinant Human Interferon ω Spray in Treatment of Viral Upper Respiratory Tract Infection in Children

NCT05859984 ·Status: UNKNOWN ·Phase: PHASE2

Phase IV Trial,The Efficacy and Safety Study of Fuganlin Oral Liquid in Children With Acute Upper Respiratory Infection

NCT02654158 ·Status: COMPLETED

NORMAL HUMAN IMMUNOGLOBULINS (IVIG) IN PATIENTS AGED 75 YEARS AND OVER, COVID-19 WITH SEVERE ACUTE RESPIRATORY FAILURE

NCT04403269 ·Status: UNKNOWN ·Phase: PHASE2

Efficacy and Safety of hzVSFv13 in Patients With COVID-19 Pneumonia

NCT04679350 ·Status: TERMINATED ·Phase: PHASE2

Effects of Fuzheng Huayu Tablets on COVID-19

NCT04645407 ·Status: COMPLETED ·Phase: PHASE4

Study of the Use of Favipiravir in Hospitalized Subjects With COVID-19

NCT04358549 ·Status: COMPLETED ·Phase: PHASE2

Study of Alferon® LDO (Low Dose Oral) in Normal Volunteers

NCT00215826 ·Status: COMPLETED ·Phase: PHASE2

Clinical Trial of Efficacy and Safety of Anaferon for Children Liquid Dosage Form in the Treatment of Acute Upper Respiratory Infections

NCT03162458 ·Status: COMPLETED ·Phase: PHASE3

Favipiravir in High-risk COVID-19 Patients

NCT04818320 ·Status: COMPLETED ·Phase: PHASE3